Literature DB >> 18415598

[Not Available].

K H Grotemeyer1.   

Abstract

Year:  1992        PMID: 18415598     DOI: 10.1007/BF02529700

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  14 in total

1.  [Not Available].

Authors:  D Soyka; H C Diener; W D Gerber; V Pfaffenrath; A Ziegler
Journal:  Schmerz       Date:  1990-06       Impact factor: 1.107

2.  [Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study].

Authors:  K H Grotemeyer; H P Schlake; I W Husstedt
Journal:  Nervenarzt       Date:  1988-09       Impact factor: 1.214

3.  [Conduction velocity and relative refractory period of the sural nerve in patients treated with ergot alkaloids].

Authors:  K H Grotemeyer; I Husstedt; H P Schlake
Journal:  EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb       Date:  1986-03

4.  Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105.

Authors:  K Ekbom
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

5.  Lisuride in cluster headache.

Authors:  E Raffaelli; O J Martins; A dos Santos P Dãgua Filho
Journal:  Headache       Date:  1983-05       Impact factor: 5.887

6.  Clinical and hemodynamic effects during treatment of vascular headaches with verapamil.

Authors:  J S Meyer; R Dowell; N Mathew; J Hardenberg
Journal:  Headache       Date:  1984-11       Impact factor: 5.887

7.  Response of cluster headache attacks to oxygen inhalation.

Authors:  L Kudrow
Journal:  Headache       Date:  1981-01       Impact factor: 5.887

8.  Tomographic determination of cerebral blood flow during attacks of cluster headache.

Authors:  A A Krabbe; L Henriksen; J Olesen
Journal:  Cephalalgia       Date:  1984-03       Impact factor: 6.292

9.  Absorption of effervescent aspirin during migraine.

Authors:  G N Volans
Journal:  Br Med J       Date:  1974-11-02

10.  Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine.

Authors:  A Doenicke; J Brand; V L Perrin
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.